The consumer division re-launched Scotch-Brite scrub pad with new packaging ... to grow strongly with significant contribution from Pharmaceutical, Automotive and General Engineering Sectors.

Shanghai and Shenzhen stock exchanges had a net outflow of 29.498 billion yuan of main funds throughout the day, of which the net outflow of main funds on the Science and Technology Innovation Board ...

While technology is sometimes a hit-or-miss affair, particularly with the intrusions of innovation occasionally outweighing its conveniences, the best pharmaceutical stocks typically enjoy ...

Based on the terms of the agreement, BridgeBio will receive a $30 million milestone payment upon approval in Japan, as well ...

We recently published a list of Was Jim Cramer Right About These 23 Stocks?. In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against ...

This is an expected part of investing, especially when it comes to growth stocks. Teva Pharmaceutical (NYSE: TEVA) is my worst-performing stock so far in 2025, down 27% in less than three months ...

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East ...

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with ...

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...

We recently published a list of Was Jim Cramer Right About These 23 Stocks?. In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...